Skip to main content
Clinical Trials/ISRCTN42992782
ISRCTN42992782Completed未知

High frequency oscillation versus lung-protective ventilation using conventional ventilators to reduce Acute Respiratory Distress Syndrome (ARDS) mortality: a randomised, parallel, two armed, multicentre pilot trial

McMaster University (Canada)0 sites60 target enrollmentStarted: May 31, 2007Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Patients of either sex, 16 years and above
  • 2. Acute onset of respiratory failure, with fewer than two weeks of new pulmonary symptoms
  • 3. Endotracheal intubation or tracheostomy
  • 4. Hypoxaemia: defined as a partial pressure of oxygen in arterial blood (PaO2)/fraction of inspired oxygen (FiO2) ratio of less than or equal to 200 mmHg
  • 5. Bilateral alveolar consolidation (airspace disease) seen on frontal chest radiograph

Exclusion Criteria

  • 1. Remaining duration of mechanical ventilation less than 48 hours, as judged by the attending physician
  • 2. Primary cause of acute respiratory failure judged by attending physician to be cardiac in origin
  • 3. Lack of commitment to ongoing life support
  • 4. Weight less than 35 kg
  • 5. Severe chronic respiratory disease
  • 6. Morbid obesity: defined as greater than 1 kg/cm body height
  • 7. Neurological conditions with risk of intracranial hypertension (hypercapnia should be avoided)
  • 8. Neuromuscular disease that will result in prolonged need for mechanical ventilation
  • 9. Previous enrolment in this trial
  • 10. All inclusion criteria present for greater than 72 hours
  • 11. On high frequency oscillator (HFO) at the time of screening

Investigators

Sponsor
McMaster University (Canada)

Similar Trials